1. CR related sales will tapper out from Friday meaning price...

1. CR related sales will tapper out from Friday meaning price will to tend to move back up to preCR price 31c
2. 29 days to EMA opinion on CE Mark approval meaning sales can start almost everywhere except North America if favourable.
3. They cant ask new questions on new topics, have delayed the approval long enough that its starting to get embarassing and the company has had long enough to give detailed answers in the submitted and accepted response.
4. On a favourable opinion FDA trial funding will be secured on good terms
5. Fantastic demographics as world moves to western diet the huge current market gets bigger and bigger.
6. A great product, cheap to make that reduces time hospital stay and labour intensive treatment of unhealing wounds, plus greatly reduced scarring and for a very common ailment.

Here is the sales estimates for Jun start.

	Column 1	Column 2	Column 3	Column 4	Column 5	Column 6	Column 7	Column 8	Column 9	Column 10	Column 11	Column 12
0	Quarter Ended	Sales	Margin	GP	Qtr OH	NPBT	TAX	NPAT	SHARES	EPS PQ	PE	Implied SP
1	Dec/14	-	75.0%	-	2.50	-    2.50	-	-    2.50	270	-$ 0.0093	21	Speculative
2	Mar/15	-	75.0%	-	5.00	-    5.00	-	-    5.00	300	-$ 0.0167	21	Speculative
3	Jun/15	2.6	75.0%	1.95	5.00	-    3.05	-	-    3.05	350	-$ 0.0087	21	Speculative
4	Sep/15	4.0	75.0%	2.98	5.00	-    2.02	-	-    2.02	350	-$ 0.0058	44	Speculative
5	Dec/15	6.1	75.0%	4.56	5.00	-    0.44	-	-    0.44	350	-$ 0.0012	44	Speculative
6	Mar/16	9.3	75.0%	6.98	7.50	-    0.52	-	-    0.52	350	-$ 0.0015	44	Speculative
7	Jun/16	14.2	75.0%	10.68	7.50	3.18	-	3.18	350	$ 0.0091	44	$1.60
8	Sep/16	18.2	75.0%	13.64	7.50	6.14	1.8	4.30	350	$ 0.0123	44	$2.16
9	Dec/16	23.2	75.0%	17.42	7.50	9.92	3.0	6.95	350	$ 0.0198	44	$3.49
10	Mar/17	29.7	75.0%	22.26	10.00	12.26	3.7	8.58	350	$ 0.0245	28	$2.75
11	Jun/17	37.9	75.0%	28.43	10.00	18.43	5.5	12.90	350	$ 0.0369	28	$4.13
12	Sep/17	50.7	75.0%	38.01	10.00	28.01	8.4	19.60	350	$ 0.0560	28	$6.27
13	Dec/17	67.7	75.0%	50.80	10.00	40.80	12.2	28.56	350	$ 0.0816	28	$9.14
14	Mar/18	90.5	75.0%	67.91	12.50	55.41	16.6	38.79	350	$ 0.1108	28	$12.41
15	Jun/18	121.0	75.0%	90.78	12.50	78.28	23.5	54.79	350	$ 0.1566	28	$17.53
16	Sep/18	127.2	75.0%	95.40	12.50	82.90	24.9	58.03	350	$ 0.1658	28	$18.57
17	Dec/18	133.7	75.0%	100.26	12.50	87.76	26.3	61.43	350	$ 0.1755	28	$19.66
18	Mar/19	140.5	75.0%	105.36	15.00	90.36	27.1	63.25	350	$ 0.1807	28	$20.24
19	Jun/19	147.6	75.0%	110.73	15.00	95.73	28.7	67.01	350	$ 0.1915	28	$21.44
20	Sep/19	154.6	75.0%	115.91	15.00	100.91	30.3	70.64	350	$ 0.2018	28	$22.60
21	Dec/19	161.8	75.0%	121.34	15.00	106.34	31.9	74.44	350	$ 0.2127	28	$23.82
22	Mar/20	169.4	75.0%	127.02	17.50	109.52	32.9	76.67	350	$ 0.2190	26	$22.78
23	Jun/20	177.3	75.0%	132.97	17.50	115.47	34.6	80.83	350	$ 0.2309	26	$24.02
24	Sep/20	184.7	75.0%	138.50	17.50	121.00	36.3	84.70	350	$ 0.2420	26	$25.17
25	Dec/20	192.3	75.0%	144.26	17.50	126.76	38.0	88.73	350	$ 0.2535	26	$26.37